According to recent findings, the Global Type-2 Diabetes Market is projected to grow at a CAGR of around 8.0% during the forecast period, i.e., 2023-28.

At MarkNtel Advisors, we continuously monitor and analyze industry trends to provide reliable insights that support informed decision-making and the key factors contributing to the market's promising outlook.

Type-2 Diabetes Overview:

The market growth is favorably fostered by the increasing prevalence of type 2 diabetes stemming from unhealthy lifestyles, physical inactivity, and obesity. According to WHO, around 422 million people worldwide have diabetes, out of which the majority live in low-and middle-income countries. In addition, diabetes accounts for more than 1.5 million deaths each year. The number of cases and the prevalence of diabetes have witnessed expansion over the past few decades.  In addition, the rising geriatric population, along with the surging population with type-1 diabetes and the lack of proper healthcare infrastructure in emerging countries, are projected to boost the growth of the type-2 Diabetes market globally in the forthcoming years.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Explore the Insights – Download a Sample Report for Free: https://www.marknteladvisors.com/query/request-sample/global-type-2-diabetes-market.html

Type-2 Diabetes Outlook and Opportunities:

Inclusion of The New Therapeutic Compounds - The introduction of new medicinal substances with enhanced efficacy and safety into the type 2 diabetes market globally has created the potential for the creation of new treatments. Therapeutic treatments with a unique MoA are offered by drugs such DPP4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, colesevelam, and bromocriptine QR. Additionally, they stop weight gain and lessen the chance of hypoglycemia. Despite the fact that not everyone should take these medications, they give medical professionals a number of alternatives for tailoring patient care and improving healthcare. The introduction of biosimilar pharmaceuticals is anticipated to increase at a quick rate over the anticipated period because of their low cost, strict product quality control standards, and straightforward production processes.

Global Type-2 Diabetes Segmentation Analysis:

By Drug Type

  • Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
  • Alpha-glucosidase Inhibitors
  • Biguanides
  • Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
  • Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2)
  • Sulfonylureas
  • Other (Thiazolidinediones, Meglitinides, Glitazones, etc.)

By Gender

  • Male
  • Female

According to reports,Between the two, the Women segment held a significant market share in the Global Type-2 Diabetes market in 2022, owing to the alarming rise in the prevalence of type-2 diabetes among pregnant women. 

By Age Group

  • Upto 19 years
  • 20 – 65 years
  • Above 65 years

By Region

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific.

According to reports, Here, North America captured a considerable market share in the Global Type-2 Diabetes market in 2022, with The US acquiring the majority market share in the region. 

For deeper insights into the market, explore the summary of the research report – https://www.marknteladvisors.com/research-library/global-type-2-diabetes-market.html

Some of the Market players in the Global Type-2 Diabetes are:

  • Merck & Co
  • AstraZeneca
  • Novo Nordisk
  • Bristol-Myers Squibb
  • Eli Lilly
  • Sanofi
  • Boehringer Ingelheim
  • Pfizer
  • Takeda
  • Biocon
  • Johnson & Johnson.

Report Delivery Format – Market research reports from MarkNtel Advisors are delivered in PDF, Excel, and PowerPoint formats. Once the payment is successfully processed, the report will be sent to your registered email within 24 hours.

Key Highlights of the Report – Unlock Valuable Market Insights

  • Market Size, Share & Future Projections – Understand the current market dimensions and forecasted growth trajectory.
  • In-Depth Pricing Analysis – Get clarity on pricing trends and cost structures across segments.
  • Company Strategies & Developments – Discover recent mergers, acquisitions, partnerships, and innovations.
  • Key Stakeholders & Value Chain Insights – Identify the main players and their roles within the industry ecosystem.
  • Import & Export Dynamics – Analyze global trade flows, regional export trends, and supply chain movements.
  • Competitive Benchmarking – Gain a clear view of the leading companies and their market positioning.
  • Emerging Growth Opportunities – Spot untapped areas and niche markets for potential investment.
  • Market Trends & Growth Drivers – Stay ahead with insights into evolving consumer behavior and industry indicators.

Research Methodology Summary

A systematic approach is used to ensure accurate market insights, combining both bottom-up and top-down methods. Data triangulation validates findings from multiple angles.

Key Steps:

  • Define objectives and research design
  • Collect data through surveys and interviews
  • Analyze and validate data using reliable tools
  • Forecast trends and deliver actionable insights

Request full methodology or customized analysis – https://www.marknteladvisors.com/query/request-customization/global-type-2-diabetes-market.html

Read Blog:

About Us – MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Visit our Website: https://www.marknteladvisors.com